VIVO OPPORTUNITY, LLC purchased 249.23K shares of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $391.6K. The strongest form of insider conviction signal.
Common Shares
Shares
+51.06K
Price / share
$1.56
Trade value
$79.65K
% of position
Common Shares
Shares
+5.15K
Price / share
$1.56
Trade value
$8.04K
% of position
Common Shares
Shares
+30.88K
Price / share
$1.69
Trade value
$52.19K
% of position
Common Shares
Shares
+3.12K
Price / share
$1.69
Trade value
$5.27K
% of position
Common Shares
Shares
+16.16K
Price / share
$1.57
Trade value
$25.38K
% of position
Common Shares
Shares
+1.63K
Price / share
$1.57
Trade value
$2.56K
% of position
Common Shares
Shares
+14.84K
Price / share
$1.55
Trade value
$23K
% of position
Common Shares
Shares
+1.50K
Price / share
$1.55
Trade value
$2.32K
% of position
Common Shares
Shares
+20.75K
Price / share
$1.52
Trade value
$31.54K
% of position
Common Shares
Shares
+2.10K
Price / share
$1.52
Trade value
$3.18K
% of position
Common Shares
Shares
+7.07K
Price / share
$1.55
Trade value
$10.96K
% of position
Common Shares
Shares
+714.00
Price / share
$1.55
Trade value
$1.11K
% of position
Common Shares
Shares
+6.13K
Price / share
$1.57
Trade value
$9.62K
% of position
Common Shares
Shares
+618.00
Price / share
$1.57
Trade value
$970.26
% of position
Common Shares
Shares
+49.97K
Price / share
$1.57
Trade value
$78.45K
% of position
Common Shares
Shares
+5.04K
Price / share
$1.57
Trade value
$7.92K
% of position
Common Shares
Shares
+29.52K
Price / share
$1.52
Trade value
$44.87K
% of position
Common Shares
Shares
+2.98K
Price / share
$1.52
Trade value
$4.53K
% of position
Net shares
+249.23K
Net value
$391.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 5/20/2026 | P · Purchase | +51.06K | $1.56 | $79.65K | 10.4% | 492.07K | 543.13K |
| Common Shares Indirect | 5/20/2026 | P · Purchase | +5.15K | $1.56 | $8.04K | 10.4% | 49.68K | 54.83K |
| Common Shares Indirect | 5/21/2026 | P · Purchase | +30.88K | $1.69 | $52.19K | 5.7% | 543.13K | 574.01K |
| Common Shares Indirect | 5/21/2026 | P · Purchase | +3.12K | $1.69 | $5.27K | 5.7% | 54.83K | 57.95K |
| Common Shares Indirect | 5/29/2026 | P · Purchase | +16.16K | $1.57 | $25.38K | 2.8% | 574.01K | 590.17K |
| Common Shares Indirect | 5/29/2026 | P · Purchase | +1.63K | $1.57 | $2.56K | 2.8% | 57.95K | 59.58K |
| Common Shares Indirect | 6/1/2026 | P · Purchase | +14.84K | $1.55 | $23K | 2.5% | 590.17K | 605.01K |
| Common Shares Indirect | 6/1/2026 | P · Purchase | +1.50K | $1.55 | $2.32K | 2.5% | 59.58K | 61.08K |
| Common Shares Indirect | 6/2/2026 | P · Purchase | +20.75K | $1.52 | $31.54K | 3.4% | 605.01K | 625.77K |
| Common Shares Indirect | 6/2/2026 | P · Purchase | +2.10K | $1.52 | $3.18K | 3.4% | 61.08K | 63.18K |
| Common Shares Indirect | 6/3/2026 | P · Purchase | +7.07K | $1.55 | $10.96K | 1.1% | 625.77K | 632.84K |
| Common Shares Indirect | 6/3/2026 | P · Purchase | +714.00 | $1.55 | $1.11K | 1.1% | 63.18K | 63.89K |
| Common Shares Indirect | 6/4/2026 | P · Purchase | +6.13K | $1.57 | $9.62K | 1.0% | 632.84K | 638.96K |
| Common Shares Indirect | 6/4/2026 | P · Purchase | +618.00 | $1.57 | $970.26 | 1.0% | 63.89K | 64.51K |
| Common Shares Indirect | 6/5/2026 | P · Purchase | +49.97K | $1.57 | $78.45K | 7.8% | 638.96K | 688.93K |
| Common Shares Indirect | 6/5/2026 | P · Purchase | +5.04K | $1.57 | $7.92K | 7.8% | 64.51K | 69.55K |
| Common Shares Indirect | 6/8/2026 | P · Purchase | +29.52K | $1.52 | $44.87K | 4.3% | 688.93K | 718.44K |
| Common Shares Indirect | 6/8/2026 | P · Purchase | +2.98K | $1.52 | $4.53K | 4.3% | 69.55K | 72.53K |
| Total | +249.23K | $391.55K | ||||||